Free webinar 29 July | Fragile X syndrome | Clinical trials in Australia

July 28th, 2021

On 29 July we hosted a practical discussion and Q&A on how clinical trials contribute to the development of treatments for Fragile X syndrome, and an overview of upcoming clinical trials in Australia.

The speakers are exceptionally well versed in Fragile X syndrome and the conduct of clinical trials, and are well known to many families.

Dr Honey Heussler, ¬†Queensland Children’s Hospital
Michael Duhig, Clinical Research Manager at Queensland Children’s Hospital
Prof David Amor, Royal Children’s Hospital, Melbourne
Dr Natalie Silove, Westmead Children’s Hospital, Sydney for Q&A
Prof Ted Brown
, President, FXAA

The recording of the webinar is now online:

The webinar is hosted by Fragile X Association of Australia, and supported by Zynerba Pharmaceuticals.



You can help us make a difference

Fragile X Association of Australia is a registered charity, funded by donations and fundraising. Donations of $2.00 and over are tax deductible. Your donation will help us support families affected by Fragile X, and to increase awareness of Fragile X associated conditions.

Make a donation
Fragile X Logo
Registered Charity Logo